NEVVI Medicare utilization intelligence
or

← back

Provider profile

MICHELS, LISA M.D.

Dermatology · NPI 1811082464 · DAVIS, CA

1
Groups
14
Codes · 2024
2,031
Disclosed services

MICHELS, LISA is a Dermatology in DAVIS, CA, a member of 1 medical group, who billed 14 distinct codes to Medicare Part B in 2024.

Groups: SUTTER VALLEY MEDICAL FOUNDATION (SACRAMENTO, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider analytics (2024)

MICHELS, LISA billed 2,039 disclosed services in CY2023 and 2,031 in CY2024.

This provider's disclosed Medicare payments across all codes were $ in CY2024.

The full figure is part of the market analytics platform — built, not launched yet. Notify me at launch →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
17000 Destruction of precancer skin growth, 1 growth
11102 Biopsy of related skin growth, first growth
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17110 Destruction of skin growth, 1-14 growths
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
17004 Destruction of precancer skin growth, 15 or more growths
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
11103 Biopsy of related skin growth, each additional growth
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
11900 Injection into skin growth, 1-7 growths
17282 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.